LTi cells form a distinct lineage in the family of "innate lymphoid cells"(ILCs). ILCs are a heterogeneous collection of lymphocytes that lack antigen specificity(non-T, non-B cells) and potentially produce characteristic cytokines of T cell subsets (Th1, Th2, Th17). Innate lymphoid cells are sessile cells. They do not circulate through the bloodstream and therefore belong to the local organ tissue where they are produced when needed.
ILCs are classified into group 1 (ILC1s), group 2 (ILC2s) or group 3 (ILC3s) (Doherty TA et al. 2019). They are important players in the innate immune system and perform a central role in the defense against infectious agents but are also associated with asthma, allergic rhinitis, chronic rhinosinusitis, food allergies and eosinophilic esophagitis (Bartemes KR et al. 2021).
LTi cells, which develop and function primarily in the fetal stage, and LTi-like cells, which presumably arise in adulthood, are considered a subset of type 3 ILCs (ILC3s) because they express the ILC3 lineage-defining transcription factor RORγt and, like other ILC3s, can produce an ILC3 signature cytokine, IL-22, and initiate protective immune responses against extracellular bacteria. However, LTi/LTi-like cells have a unique gene expression pattern, and they develop from a precursor that is distinct from the precursor of all other ILCs and the precursor of conventional natural killer (cNK) cells. LTi cells play a central role in lymphoid organogenesis (Zhong C et al. 2018).